デュシェンヌ型筋ジストロフィーに対する 新規核酸医薬技術を開発~核内送達を高めた二本鎖型核酸で治療効果の向上を実証~

ad

2025-05-22 東京科学大学

東京科学大学と大阪大学の研究グループは、デュシェンヌ型筋ジストロフィー(DMD)に対する新たな核酸医薬「HDSSO(ヘテロ二本鎖核酸SSO)」を開発しました。これは核内送達効率を高め、エクソンスキッピング活性を従来より大幅に向上させる技術です。in vitroおよびモデルマウスで高い治療効果が確認され、今後のスプライシング制御医薬の基盤技術として期待されます。研究成果は「Molecular Therapy – Nucleic Acids」誌に掲載されました。

デュシェンヌ型筋ジストロフィーに対する 新規核酸医薬技術を開発~核内送達を高めた二本鎖型核酸で治療効果の向上を実証~
LNAベースのSSOでは、Singleや相補鎖DNAのHDSSOよりも相補鎖RNAかつ5’/3’末端のみPS修飾のHDSSOでよりエクソンスキッピング活性が高く、mdxマウスでもその効果が見られた。

<関連情報>

ヘテロ二重鎖オリゴヌクレオチドのエクソンスキッピング活性に及ぼす化学修飾の影響 Effect of chemical modification on the exon-skipping activity of heteroduplex oligonucleotides

Takenori Shimo ∙ Juri Hasegawa ∙ Kotaro Yoshioka ∙ … ∙ Tetsuya Nagata ∙ Takanori Yokota ∙ Satoshi Obika
Molecular Therapy – Nucleic Acids  Published:January 31, 2025
DOI:https://doi.org/10.1016/j.omtn.2025.102468

Abstract

We applied heteroduplex oligonucleotide (HDO) technology, which uses an oligonucleotide hybridized with a complementary strand, to efficiently deliver locked nucleic acid (LNA)-based splice-switching oligonucleotides (SSOs) to the nucleus. Using an in vitro assay involving cationic lipids, we revealed that HDO technology increased the exon-skipping activity of LNA-based SSOs. To assess the effect of heteroduplex SSOs (HDSSOs) on exon-skipping activity, we designed and evaluated various HDSSOs using a series of complementary oligonucleotides with different sugar chemistries (DNA, RNA, and LNA), linkages (phosphodiester; PO and phosphorothioate; PS linkages), and lengths. HDO with different complementary oligonucleotide designs demonstrated a variety of exon-skipping activities. Next, we investigated the intracellular behavior of HDOs, which seemed to affect their efficient exon-skipping activity. We found that HDO technology increased the uptake of both SSOs and complementary oligonucleotides into the nuclei. Additionally, a series of complementary oligonucleotides showed different intracellular stabilities, and complementary oligonucleotide design appears to be one of the key factors affecting efficient exon skipping. Finally, we examined the exon-skipping activity of HDSSOs in mdx mice and found that HDSSOs exhibited higher exon-skipping activity than single-stranded LNA-based SSOs in these mice under intramuscular injections.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました